Literature DB >> 10440217

Metaplastic polyp of the colon develops in response to inflammation.

S Higaki1, A Akazawa, H Nakamura, H Yanai, T Yoshida, K Okita.   

Abstract

BACKGROUND: The metaplastic polyp of the colon is a non-neoplastic lesion that is generally identified as white, flat and having a smooth surface. In general, this polyp is small, is less than 5 mm in diameter but is occasionally larger than 5 mm in diameter, and forms a swelling. The aims of the present study were to clarify the factors that determine the morphology of protruding metaplastic polyps. More specifically, we investigated whether the metaplastic polyp forms as a result of an abnormality in cell proliferation or inflammation of the region.
METHODS: We examined 15 endoscopically resected metaplastic polyps of the colon having a longitudinal diameter of more than 5 mm. To study aspects of cell proliferation, we used proliferating-cell nuclear antigen (PCNA) staining. For examination of histological changes caused by inflammation, we used alpha-smooth muscle actin (alphaSMA) staining, in which myofibroblasts are specifically stained.
RESULTS: Metaplastic polyps showed significantly higher expression of PCNA, not only in the deep layer, but also in the intermediate and superficial layers, compared with the normal mucosa of the colon. In the protruding metaplastic polyps, anti-alphaSMA staining revealed bundle-like myofibroblasts in the interstitium.
CONCLUSIONS: The factors responsible for the formation of non-neoplastic metaplastic polyps larger than 5 mm with a protruding morphology are: an increased number of epithelial cells due to the movement of these cells toward the ductal epithelium in the proliferating zone; and expansion of interstitial tissues due to infiltration of myofibroblasts and other inflammatory cells in response to inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440217     DOI: 10.1046/j.1440-1746.1999.01938.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  CARD15 mutations and colorectal cancer in a South European country.

Authors:  Paulo Freire; Francisco Portela; Maria M Donato; Pedro Figueiredo; Manuela Ferreira; Pedro Amaro; Anabela Sá; Paulo Andrade; Hermano Gouveia; Carlos Sofia
Journal:  Int J Colorectal Dis       Date:  2010-07-30       Impact factor: 2.571

2.  A prospective evaluation of C-reactive protein levels and colorectal adenoma development.

Authors:  Marc J Gunter; Amanda J Cross; Wen-Yi Huang; Frank Z Stanczyk; Mark Purdue; Xiaonan Xue; Robert Schoen; Paul J Limburg; Arthur Schatzkin; Rashmi Sinha; Richard B Hayes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-06       Impact factor: 4.254

3.  Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.

Authors:  Y Okugawa; C Miki; Y Toiyama; H Yasuda; T Yokoe; S Saigusa; J Hiro; K Tanaka; Y Inoue; M Kusunoki
Journal:  Br J Cancer       Date:  2010-09-07       Impact factor: 7.640

4.  Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer.

Authors:  Bríd M Ryan; Krista A Zanetti; Ana I Robles; Aaron J Schetter; Julie Goodman; Richard B Hayes; Wen-Yi Huang; Mark J Gunter; Meredith Yeager; Laurie Burdette; Sonja I Berndt; Curtis C Harris
Journal:  Int J Cancer       Date:  2013-11-14       Impact factor: 7.396

5.  Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis.

Authors:  Yoku Hayakawa; Shin Maeda; Hayato Nakagawa; Yohko Hikiba; Wataru Shibata; Kei Sakamoto; Ayako Yanai; Yoshihiro Hirata; Keiji Ogura; Susumu Muto; Akiko Itai; Masao Omata
Journal:  J Gastroenterol       Date:  2009-06-26       Impact factor: 7.527

6.  Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.

Authors:  Peter Laszlo Lakatos; Erika Hitre; Ferenc Szalay; Kerstin Zinober; Peter Fuszek; Laszlo Lakatos; Simon Fischer; Janos Osztovits; Orsolya Gemela; Gabor Veres; Janos Papp; Peter Ferenci
Journal:  BMC Cancer       Date:  2007-03-27       Impact factor: 4.430

7.  The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival.

Authors:  C Evans; I Morrison; A G Heriot; J B Bartlett; C Finlayson; A G Dalgleish; D Kumar
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

Review 8.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.